project id: TCGA-BRCA; case submitter id: TCGA-E2-A1BC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 63; days to birth: -23168; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1947; age at diagnosis: 23168; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 501.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8524/3; primary diagnosis: Infiltrating lobular mixed with other types of carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 275; days to sample procurement: 0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent stromal cells: 0.0;